Table 2.
Cell Type | Treament | Targeted Pathway |
---|---|---|
293TcHSF1 | arsenite (As(III)) | H5R/OSR/ISR |
293TcHSF1 | dox-HSFI | HSR |
293DAX | dox-XBPIs | XBP1s |
293DAX | DHFR.ATF6 | ATF6 |
293DAX | dox-XBP1s+DHFR.ATF6 | XBP1S+ATF6 |
293DAX | thapsigargin (Tg) | UPR |
293T | thapsigargin (Tg) | UPR |
293T | tunicamycin (Tm) | UPR |
293T | oligomycin | ISR/OSR |
293T | paraquat | ISR/OSR |
293T | CBR-470–1 | OSR |
293T | bardoxolone | OSR |
293T | A3 | HSR |
293T | Cl | HSR |
293T | D1 | HSR |
293T | FI | HSR |